Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2011-07-15 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January to June 2011. It contains comprehensive financial data, including income statements, cash flow, and detailed management commentary on market performance, research and development, and regional sales analysis. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2011
2011-07-15 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January – June 2011' and contains comprehensive financial data, including net sales, operating profit, earnings per share, and cash flow for the specified period. It also includes detailed management commentary, market analysis, and segment reporting. As it provides substantive financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2011
2011-07-15 English
Kommuniké från årsstämma i CellaVision AB (publ) den 26 april 2011
AGM Information Classification · 1% confidence The document is titled "Kommuniké från årsstämma i CellaVision AB (publ) den 26 april 2011" (Communication from the Annual General Meeting in CellaVision AB (publ) on April 26, 2011). It explicitly details decisions made at the AGM regarding profit distribution, discharge of the board/CEO, board composition/remuneration, incentive programs, authorization for share issuance, and changes to the articles of association. Furthermore, it includes a section titled "CellaVisions årsstämma 2011" and a speech by the CEO, which are typical components of AGM materials. This strongly indicates the document is related to the Annual General Meeting. The most specific code for this is AGM-R (AGM Information). Although it contains financial updates (like Q1 2011 summary and 2010 results), the primary context and structure revolve around the formal decisions taken at the shareholder meeting.
2011-04-26 Swedish
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 26, 2011
AGM Information Classification · 1% confidence The document explicitly states it contains the 'Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 26, 2011' and details the resolutions passed at the 'Annual General Meeting (AGM)'. It also includes the CEO's address and presentation slides related to the meeting. This content directly corresponds to the definition of AGM Information.
2011-04-26 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for CellaVision covering the period from January 1 to March 31, 2011. It includes detailed financial statements (income statement, cash flow, balance sheet data), management commentary, analysis of market performance, research and development updates, and a formal declaration by the Board and CEO. It is clearly an interim financial report, not an announcement of one, as it contains the substantive financial data and analysis required for an 'Interim / Quarterly Report' (IR). Q1 2011
2011-04-20 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period January 1 to March 31, 2011. It contains detailed financial statements, including net sales, operating profit, cash flow, and balance sheet data, as well as management commentary on business performance, market conditions, and risks. It explicitly identifies itself as an 'Interim report' and includes a certification by the Board of Directors and CEO. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2011
2011-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.